DK0460882T3 - Lipopeptiddeacylase - Google Patents

Lipopeptiddeacylase

Info

Publication number
DK0460882T3
DK0460882T3 DK91304976.3T DK91304976T DK0460882T3 DK 0460882 T3 DK0460882 T3 DK 0460882T3 DK 91304976 T DK91304976 T DK 91304976T DK 0460882 T3 DK0460882 T3 DK 0460882T3
Authority
DK
Denmark
Prior art keywords
enzyme
deacylase
lipid
cyclicpeptide
aculeacin
Prior art date
Application number
DK91304976.3T
Other languages
Danish (da)
English (en)
Inventor
Wu-Kuang Yeh
Adam Joseph Kreusman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0460882T3 publication Critical patent/DK0460882T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y10S435/815—Enzyme separation or purification by sorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
DK91304976.3T 1990-06-07 1991-06-03 Lipopeptiddeacylase DK0460882T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53439490A 1990-06-07 1990-06-07

Publications (1)

Publication Number Publication Date
DK0460882T3 true DK0460882T3 (da) 1996-08-26

Family

ID=24129856

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91304976.3T DK0460882T3 (da) 1990-06-07 1991-06-03 Lipopeptiddeacylase

Country Status (14)

Country Link
US (1) US5573936A (ko)
EP (1) EP0460882B1 (ko)
JP (1) JP2994486B2 (ko)
KR (1) KR0169994B1 (ko)
AT (1) ATE140728T1 (ko)
CA (1) CA2043762C (ko)
DE (1) DE69121018T2 (ko)
DK (1) DK0460882T3 (ko)
ES (1) ES2089133T3 (ko)
GR (1) GR3021292T3 (ko)
HU (1) HU215232B (ko)
IE (1) IE75885B1 (ko)
IL (1) IL98349A (ko)
TW (1) TW197471B (ko)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743777B1 (en) 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
ATE439433T1 (de) * 1996-03-08 2009-08-15 Astellas Pharma Inc Prozess für die deacylierung von zyklischen lipopeptiden.
US6146872A (en) * 1996-06-13 2000-11-14 Fukisawa Pharmaceutical Co., Ltd. Cyclic lipopeptide acylase
US6361988B1 (en) 1997-03-25 2002-03-26 California Institute Of Technology ECB deacylase mutants
US6153410A (en) * 1997-03-25 2000-11-28 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
US5936074A (en) * 1997-04-17 1999-08-10 Eli Lilly And Company Teicoplanin deacylation process and product
US6323176B1 (en) 1998-02-25 2001-11-27 Eli Lilly And Company Cyclic peptide antifungal agents
DK1137663T3 (da) 1998-12-09 2007-01-08 Lilly Co Eli Oprensning af Echinocandin-cyclopeptidforbindelser
CN1345230A (zh) 1999-03-03 2002-04-17 伊莱利利公司 口服ecb药物制剂和药物组合物的制备方法
BR0008712A (pt) 1999-03-03 2001-12-26 Lilly Co Eli Complexos equinocandina/carboidrato
KR20020002476A (ko) 1999-03-03 2002-01-09 피터 지. 스트링거 결정질 에키노칸딘 암모늄염의 형성 및 음이온 교환
CN100335122C (zh) 1999-03-03 2007-09-05 伊莱利利公司 含有成胶束表面活性剂的棘白菌素药物制剂
HUP0202315A2 (en) * 1999-07-15 2002-10-28 Lilly Co Eli Process for deacylation of lipodepsipeptides
EP2295444A3 (en) * 1999-12-15 2011-03-23 Cubist Pharmaceutical Inc. Lipopeptides as antibacterial agents
KR20020063230A (ko) * 1999-12-15 2002-08-01 큐비스트 파마슈티컬즈 인코포레이티드 항균제로서의 신규한 리포펩티드
KR20020063228A (ko) * 1999-12-15 2002-08-01 큐비스트 파마슈티컬즈 인코포레이티드 항균제로서 리포펩티드
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
AU2002353775A1 (en) * 2001-08-06 2003-03-10 Cubist Pharmaceuticals, Inc. Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
DE102004060750A1 (de) * 2004-12-15 2006-07-13 Sanofi-Aventis Deutschland Gmbh Verfahren zur Deacylierung von Lipopeptiden
CA2747965C (en) * 2008-12-22 2017-06-27 Cubist Pharmaceuticals, Inc. Novel antibacterial agents for the treatment of gram positive infections
US9394340B2 (en) * 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
CN104768966B (zh) 2012-09-24 2018-11-02 中化帝斯曼制药有限公司荷兰公司 生产环肽的方法
KR101425108B1 (ko) * 2012-09-25 2014-07-31 동국제약 주식회사 탈아실화된 환상 리포펩티드의 제조방법
CN108410929B (zh) * 2018-05-30 2024-01-26 博瑞生物医药（苏州）股份有限公司 阿尼芬净前体的制备方法
CN109593809A (zh) * 2018-12-07 2019-04-09 成都雅途生物技术有限公司 一种固定化微生物酶转化棘白菌素b的方法
CN113215185B (zh) * 2021-04-22 2022-04-29 浙江工业大学 一种用于重组表达棘白菌素b脱酰基酶的重组基因序列

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1159450A (en) * 1979-12-13 1983-12-27 Manuel Debono Process for the preparation of derivatives of cyclic peptide nuclei

Also Published As

Publication number Publication date
KR0169994B1 (ko) 1999-02-01
DE69121018T2 (de) 1996-12-19
HU215232B (hu) 1998-11-30
TW197471B (ko) 1993-01-01
JPH04228072A (ja) 1992-08-18
IE75885B1 (en) 1997-09-24
EP0460882A2 (en) 1991-12-11
JP2994486B2 (ja) 1999-12-27
DE69121018D1 (de) 1996-08-29
EP0460882A3 (en) 1992-04-22
EP0460882B1 (en) 1996-07-24
IL98349A0 (en) 1992-07-15
US5573936A (en) 1996-11-12
KR920000919A (ko) 1992-01-29
ATE140728T1 (de) 1996-08-15
HU911897D0 (en) 1991-12-30
GR3021292T3 (en) 1997-01-31
IL98349A (en) 1995-05-26
ES2089133T3 (es) 1996-10-01
CA2043762C (en) 2001-05-29
IE911939A1 (en) 1991-12-18
HUT61587A (en) 1993-01-28
CA2043762A1 (en) 1991-12-08

Similar Documents

Publication Publication Date Title
ATE140728T1 (de) Lipopeptid deacylase
DE69227041T2 (de) Expression und reinigung von rekombinantem, löslichem gewebefaktor
DE69332879D1 (de) Technetium-99-markierte peptide zur visualisierung vom entzuendungen
PT1062325E (pt) Purificacao de preparacoes de virus
DK163520C (da) Substitueret androsta-1,4-dien-3,17-dioner, fremgangsmaade til fremstilling deraf, praeparater indeholdende saadanne forbindelser samt anvendelsen af disse til fremstilling af farmaceutiske praeparater
AU4052389A (en) Derivatized glass supports for peptide and protein sequencing
DK0464140T3 (da) Aktivt adhæsionspeptid
ES2179077T3 (es) Acido glutamico decarboxilasa clonada.
AU9156291A (en) Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs
HUP0003513A2 (hu) Apoptózist indukáló monoklonális antitest
DK289285A (da) Thymopentin analoge
JPH02500022U (ko)
ATE273997T1 (de) Zyklische hexapeptid somatostatin analoga
NO952336L (no) Insulin analoger
DK403384A (da) Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf
FI953093A0 (fi) Menetelmiä, joilla voidaan havaita ja hoitaa yksilöitä, joilla on epänormaaleja soluja, jotka ekspressoivat HLA-A2/tyrosinaasi-peptidiantigeenejä
PT1107981E (pt) Sintese de analogos peptidicos ciclicos de anel modificado
GB9311454D0 (en) Pharmaceutical compositions
ES2195409T3 (es) Purificacion de moleculas.
AP9100296A0 (en) Peptides and analogues and mixtures thereof for detecting antibodies to HTLV-1 and HTLV11 viruses.
ITRM920809A1 (it) Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica.
KR920011511A (ko) 항종양 면역증강효과가 있는 단백다당체(g 009)
NO891926D0 (no) Fremgangsmaate for fremstilling av stabile protein- eller peptidpreparater.
SANTIS Spherical cap harmonic analysis of local gravity field
Lopez-Trascasa et al. Isolation and characterization of a biologically active C2 derived oligopeptide